Shin Nippon Biomedical Laboratories (FRA:YB3) EBIT per Share : €1.08 (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories EBIT per Share?

Shin Nippon Biomedical Laboratories's EBIT per Share for the three months ended in Dec. 2023 was €0.18. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €1.08.

During the past 12 months, the average EBIT per Share Growth Rate of Shin Nippon Biomedical Laboratories was -20.60% per year. During the past 3 years, the average EBIT per Share Growth Rate was 18.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 37.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's EBIT per Share or its related term are showing as below:

FRA:YB3' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -101.3 Med: -1.6 Max: 71.6
Current: 18.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shin Nippon Biomedical Laboratories was 71.60% per year. The lowest was -101.30% per year. And the median was -1.60% per year.

FRA:YB3's 3-Year EBIT Growth Rate is ranked better than
74.86% of 175 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.6 vs FRA:YB3: 18.10

Shin Nippon Biomedical Laboratories's EBIT for the three months ended in Dec. 2023 was €7.4 Mil.

Shin Nippon Biomedical Laboratories EBIT per Share Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories EBIT per Share Chart

Shin Nippon Biomedical Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

0.67

0.81

1.53

1.32

1.05

Shin Nippon Biomedical Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.36	0.31	0.29	0.18	0.31

Shin Nippon Biomedical Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shin Nippon Biomedical Laboratories's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	43.681	/	41.632
=	1.05

Shin Nippon Biomedical Laboratories's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	7.375	/	41.632
=	0.18

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.08

Shin Nippon Biomedical Laboratories (FRA:YB3) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shin Nippon Biomedical Laboratories EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

2395:Japan

Address

8-1 Akashi-cho, Tokyo, JPN

Website

http://www.snbl.co.jp

Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines